CROI 2017 Program and Information

Program and Agenda

136 UNRESTRICTED DAA ACCESS IN THE NETHERLANDS: RAPID THERAPY UPTAKE INHIV+HCV+PATIENTS Anne Boerekamps 1 , Astrid Newsum 2 , Colette Smit 3 , Peter Reiss 4 , Clemens Richter 5 , Marc van der Valk 6 , Joop Arends 7 , Kees Brinkman 8 , Bart Rijnders 1 , for the Netherlands ATHENA HIV observational cohort and the NVHB-SHM Hepatitis Working Group 1 Erasmus Univ Med Cntr, Rotterdam, Netherlands, 2 Pub Hlth Service of Amsterdam and Academic Med Cntr, Amsterdam, Netherlands, 3 Stichting HIV Monitoring, Amsterdam, Netherlands, 4 Stichting HIV Monitoring and Academic Med Cntr, Amsterdam, Netherlands, 5 Rijnstate Hosp, Arnhem, Netherlands, 6 Academic Med Cntr, Amsterdam, Netherlands, 7 Univ Med Cntr Utrecht, Utrecht, Netherlands, 8 OLVG, Amsterdam, Netherlands 137LB SUBSTANTIAL DECLINE IN ACUTE HCV INFECTIONS AMONG DUTCHHIV+MSMAFTER DAA ROLL OUT Rijnders 1 , for the Dutch Acute HCV in HIV (DAHHS) study group 1 Erasmus Univ Med Cntr, Rotterdam, Netherlands, 2 OLVG, Amsterdam, Netherlands, 3 Slotervaart MC, Amsterdam, Netherlands, 4 MC Haaglanden, The Hague, Netherlands, 5 Univ Medl Cntr Utrecht, Utrecht, Netherlands, 6 St. Elizabeth Ziekenhuis, Tilburg, Netherlands, 7 Rijnstate Hosp, Arnhem, Netherlands 138 CORRELATION OF RENAL BIOMARKERS AND TENOFOVIR AUC IN THE ION-4 STUDY COHORT Austin W. Chan 1 , Larry Park 1 , Lauren F. Collins 1 , Curtis Cooper 2 , Michael Saag 3 , Douglas Dieterich 4 , Mark Sulkowski 5 , Susanna Naggie 1 , for the ION-4 Study Group 1 Duke Univ, Durham, NC, USA, 2 Ottawa General Rsr Inst, Ottawa, Ontario, 3 Univ of Alabama at Birmingham, Birmingham, AL, USA, 4 Icahn Sch of Med at Mt Sinai, New York, NY, USA, 5 The Johns Hopkins Univ, Baltimore, MD, USA 139 HEPATOCELLULAR CARCINOMA AFTER SVRWITH IFN-FREE REGIMENS INHIV/HCV COINFECTION Nicolás Merchante 1 , Boris Revollo 2 , Francisco Rodríguez-Arrondo 3 , Esperanza Merino 4 , Maria J. Galindo 5 , Marta Montero 6 , Antonio Rivero- Juárez 7 , Marcial Delgado-Fernández 8 , Maria J. Rios-Villegas 9 , Juan A. Pineda 1 1 Hosp Univ de Valme, Sevilla, Spain, 2 Hosp German Trias i Pujol, Badalona, Spain, 3 Hosp Univ de Donostia, San Sebastián, Spain, 4 Hosp General Univ de Alicante, Alicante, Spain, 5 Hosp Clínico de Valencia, Valencia, Spain, 6 Hosp Univ y Politécnico La Fe, Valencia, Spain, 7 Hosp Univ Reina Sofía, Córdoba, Spain, 8 Hosp Regional Univ de Málaga, Málaga, Spain, 9 Hosp Univ Virgen Macarena, Sevilla, Spain 140 IDENTIFICATION OF HCV INTER-SUBTYPE RECOMBINANT STRAINSWITH BREAKPOINTS INNS5A Suqin Cai , Alicia Newton, Wei Huang, Jeannette Whitcomb Monogram BioScis, South San Francisco, CA, USA 141 SYNERGY BETWEEN COMBINATIONS OF ANTI-HCV BROADLY NEUTRALIZINGMONOCLONAL ANTIBODIES Madeleine C. Mankowski 1 , Andrew I. Flyak 2 , Stuart C. Ray 3 , James E. Crowe 2 , Justin R. Bailey 3 1 Johns Hopkins Univ, Severna Park, MD, USA, 2 Vanderbilt Univ, Nashville, TN, USA, 3 Johns Hopkins Univ, Baltimore, MD, USA 10:30 10:45 11:00 11:15 11:30 11:45 Anne Boerekamps 1 , Guido van den Berk 2 , Fanny Lauw 3 , Eliane Leyten 4 , Joop Arends 5 , Marjo Kasteren 6 , Mark Claassen 7 , Charles Boucher 1 , Bart

Oral Sessions • Thursday

CROI 2017 65